Filtered By:
Source: European Review for Medical and Pharmacological Sciences
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 728 results found since Jan 2013.
Tirofiban in the treatment of cancer-associated ischemic stroke
CONCLUSIONS: Early administration of tirofiban in the treatment of mild to moderate ischemic stroke is safe, which can reduce 24-hour and 7-day NIHSS scores and has potential value.PMID:37140310 | DOI:10.26355/eurrev_202304_32142
Source: European Review for Medical and Pharmacological Sciences - May 4, 2023 Category: Drugs & Pharmacology Authors: Z-M Zhang Z-H Lin G-L Zhu Source Type: research
Risk of acute stroke in patients with retinal artery occlusion: a systematic review and meta-analysis
CONCLUSIONS: The meta-analysis demonstrated that people with RAO are significantly more likely to get an acute stroke than patients without RAO. In addition, patients with RAO are substantially more likely than those without RAO to develop an acute stroke following an occlusion episode, especially if they are under 75 years old. However, given that only a small number of the studies in our review did not show a clear correlation between the two, we believe more research is required to conclusively link RAO and the prevalence of acute stroke.PMID:37401301 | DOI:10.26355/eurrev_202306_32803
Source: European Review for Medical and Pharmacological Sciences - July 4, 2023 Category: Drugs & Pharmacology Authors: O Al Jarallah Source Type: research
